SynAct Pharma AB
STO:SYNACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SynAct Pharma AB
STO:SYNACT
|
SE |
|
Aerometrex Ltd
ASX:AMX
|
AU |
|
Doximity Inc
NYSE:DOCS
|
US |
|
S
|
Sri Lotus Developers and Realty Ltd
NSE:LOTUSDEV
|
IN |
|
H
|
Hyundai Hyms Co Ltd
KOSDAQ:460930
|
KR |
|
Archer Ltd
OSE:ARCH
|
BM |
|
MSL Solutions Ltd
ASX:MSL
|
AU |
|
T
|
Thai Solar Energy PCL
SET:TSE
|
TH |
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
F
|
FirstEnergy Corp
DUS:FE7
|
US |
|
S
|
Superior Prima Sukses PT Tbk
IDX:BLES
|
ID |
|
West High Yield (WHY) Resources Ltd
XTSX:WHY
|
CA |
Wall St Price Targets
SYNACT Price Targets Summary
SynAct Pharma AB
According to Wall Street analysts, the average 1-year price target for SYNACT is 29.02 SEK with a low forecast of 28.73 SEK and a high forecast of 29.87 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SYNACT's stock price target?
Price Target
29.02
SEK
According to Wall Street analysts, the average 1-year price target for SYNACT is 29.02 SEK with a low forecast of 28.73 SEK and a high forecast of 29.87 SEK.